Detailed analysis of diffuse large B cell lymphoma patients: a single-center, retrospective study

Item

http://www.wikidata.org/entity/Q42104119

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Detailed analysis of diffuse l ...... le-center, retrospective study

@en

Detailed analysis of diffuse l ...... le-center, retrospective study

@nl

type

Item

label

Detailed analysis of diffuse l ...... le-center, retrospective study

@en

Detailed analysis of diffuse l ...... le-center, retrospective study

@nl

prefLabel

Detailed analysis of diffuse l ...... le-center, retrospective study

@en

Detailed analysis of diffuse l ...... le-center, retrospective study

@nl

P1476

Detailed analysis of diffuse l ...... le-center, retrospective study

@en

P2093

Anil Barak Dolgun

http://www.w3.org/2001/XMLSchema#string

Ayse Salihoglu

http://www.w3.org/2001/XMLSchema#string

Burhan Ferhanoglu

http://www.w3.org/2001/XMLSchema#string

M Cem Ar

http://www.w3.org/2001/XMLSchema#string

Murat Ozbalak

http://www.w3.org/2001/XMLSchema#string

Nukhet Tuzuner

http://www.w3.org/2001/XMLSchema#string

Seniz Ongoren Aydin

http://www.w3.org/2001/XMLSchema#string

Teoman Soysal

http://www.w3.org/2001/XMLSchema#string

Yildiz Aydin

http://www.w3.org/2001/XMLSchema#string

Zafer Baslar

http://www.w3.org/2001/XMLSchema#string

P2860

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Prognostic value of platelet count in diffuse large B-cell lymphoma.

Modified number of extranodal involved sites as a prognosticator in R-CHOP-treated patients with disseminated diffuse large B-cell lymphoma

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.

P304

908191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/908191

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

Ahmet Emre Eskazan

Onder Ergonul

P577

2013-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256190467

http://www.w3.org/2001/XMLSchema#string

P698

23984080

http://www.w3.org/2001/XMLSchema#string

P932

3747433

http://www.w3.org/2001/XMLSchema#string